Mark Densel
Corporate Officer/Principal chez EFFECTOR THERAPEUTICS, INC.
Postes actifs de Mark Densel
Sociétés | Poste | Début | Fin |
---|---|---|---|
EFFECTOR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2018 | - |
Historique de carrière de Mark Densel
Anciens postes connus de Mark Densel
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | - | - |
LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | - | - |
Formation de Mark Densel
Ball State University (Indiana) | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
EFFECTOR THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
- Bourse
- Insiders
- Mark Densel
- Expérience